Athira Pharma, Inc. is a clinical-stage biopharmaceutical company based in Bothell, Washington. Founded in 2011 and formerly known as M3 Biotechnology, the company focuses on advancing therapies for neuronal health. Athira Pharma is publicly traded on NASDAQ under the ticker symbol ATHA. The company's mission is to restore lives by developing small molecules aimed at treating neurological disor...